Form 8-K INTEGRA LIFESCIENCES For: Oct 31

Go back to Form 8-K INTEGRA LIFESCIENCES For: Oct 31

Integra LifeSciences (IART) PT Lowered to $58 at RBC Capital

November 1, 2018 6:41 AM EDT

RBC Capital analyst Glenn Novarro lowered the price target on Integra LifeSciences (NASDAQ: IART) to $58.00 (from $60.00) while maintaining a Sector Perform rating.

... More